REFERENCES
- Oliveira J. S.M.. 1985. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. American Heart Journal. 110: 1092–1098. [PUBMED], [INFOTRIEVE]
- Amorim D. S., Marin-Neto J. A.. 1995. Functional alterations of the autonomic nervous system in Chagas' heart disease. Revista Paulista de Medicina. 113: 772–784. [PUBMED], [INFOTRIEVE]
- Hagar J. M., Rahimtoola S. H.. 1991. Chagas' heart disease in the United States. New England Journal of Medicine. 325: 763–768. [PUBMED], [INFOTRIEVE]
- Mady C., Nacruth R. 1995. Natural history of chronic Chagas' heart disease: Prognostic factors. Revista Paulista de Medicina. 113: 791–796. [PUBMED], [INFOTRIEVE]
- Morris A. S., Tanowitz B., Wittner M., et al, 1990. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation. 82: 1900–1909. [PUBMED], [INFOTRIEVE]
- Higuchi M. L., Pereira B. A., Lopes E. A., et al, 1987. The role of active myocarditis in the development of heart failure in chronic Chagas' heart disease: A study based on endomyocardial biopsies. Clinical Cardiology. 10: 665–670. [PUBMED], [INFOTRIEVE]
- Sterin-Borda L., Borda E. 1994. Participation of autonomic nervous system in the pathogenesis of Chagas' disease. Acta Physiologica, Pharmacologica et Therapeutica Latinoamericana. 44: 109–123. [PUBMED], [INFOTRIEVE]
- Cunha-Neto E., Kalil J. 1995. Autoimmunity in Chagas' heart disease. Revista Paulista de Medicina. 113: 757–766. [PUBMED], [INFOTRIEVE]
- Rossi M. A.. 1990. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. American Heart Journal. 82: 1900–1909
- Celemajer D. S.. 1997. Endothelial dysfunction. Does it matter?. Journal of the American College of Cardiology. 30: 325–333. [CROSSREF]
- Anderson T. J.. 1999. Assessment and treatment of endothelial dysfunction in humans. Journal of the American College of Cardiology. 34: 631–638. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vapaatalo H., Mervaala E. 2001. Clinically important factors influencing endothelial function. Medical Science Monitor. 7: 1075–1085. [PUBMED], [INFOTRIEVE]
- Drexler H., Hornig B. J.. 1999. Endothelial dysfunction in human disease [Endothelial dysfunction: A novel therapeutic target]. Molecular and Cellular Cardiology. 31: 51–60. [CROSSREF]
- Schächinger V., Britten M. B., Zeiher A. M.. 2000. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 101: 1899–1906
- Rossi M. A., Ramos S. G.. 1996. Coronary microvascular abnormalities in Chagas' disease. American Heart Journal. 132: 207–210. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ramos S. G., Rossi M. A.. 1999. Microcirculation and Chagas' disease: Hypothesis and recent results. Ver Instituto de Medicina Tropical de São Paulo. 41: 123–129
- Rossi M. A.. 1997. Aortic endothelial cell changes in the acute septicemic phase of experimental Trypanosoma cruzi infection in rats: Scanning and transmission electron microscopic study. American Journal of Tropical Medicine and Hygiene. 57: 321–327. [PUBMED], [INFOTRIEVE]
- Tanovitz H. B., Wittner M., Morris A. S., Zhao W., Weiss L. M., Hatcher V. B., Braunstein V. L., Huang H., Douglas S. A., Valcic M., Spektor M., Christ G. J.. 1999. The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vascular tone induced by. Trypanossoma cruzi. Endothelium. 6: 217–330
- Camargo E. R., Machado C. R., Teixeira A. L., Jr., et al, 2002. Role of endothelin during experimental Trypanossoma cruzi infection in rats. Clinical Science (London). 103(Suppl 48)64S–67S
- Sunnermark D., Frostegard J., Orn A., et al, 1998. Cellular and cytokine characterization of vascular inflammation in CBA/J mice chronically infected with. Trypanosoma cruzi. Scandinavian Journal Immunology. 48: 480–484. [CROSSREF]
- Morris A. S., Tanowitz H., Makman M., et al, 1992. Trypanosoma cruzi: Alteration of cAMP metabolism following infection of human endothelial cell. Experimental Parasitology. 74: 69–76. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Torres F. W., Acquatella H., Condado J. A., et al, 1995. Coronary vascular reactivity is abnormal in patients with Chagas' heart disease. American Heart Journal. 129: 995–1001. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marin-Neto J. A., Marzullo P., Marcassa C., et al, 1992. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by Thallium-201 scintigraphy. American Journal of Cardiology. 69: 780–784. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marin-Neto J. A., Simões M. V., Ayres-Neto E. M., et al, 1995. Studies of the coronary circulation in Chagas' heart disease. São Paulo Medical Journal. 113: 826–831
- Treasure C. B., Vita J. A., Cox D. A., et al, 1990. Endothelium-dependent vasodilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81: 772–779. [PUBMED], [INFOTRIEVE]
- Katz S. D., Biasucci L., Sabba C., et al, 1992. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. Journal of the American College of Cardiology. 19: 918–925. [PUBMED], [INFOTRIEVE]
- Barreto-Filho J. A.S., Consolim-Colombo F. M., Lopes H. F., et al, 2000. Dysregulation of peripheral and central chemoreflex responses in Chagas' disease patients without heart failure. Circulation. 104: 1792–1798
- Whitney R. J.. 1953. Measurement of volume changes in human limbs. Journal of Physiology (London). 121: 1–27
- Consolim-Colombo F. M., Barreto Filho J. A., Lopes H. F., et al, 2000. Decreased cardiopulmonary baroreflex sensitivity in Chagas' heart disease. Hypertension. 36: 1035–1039. [PUBMED], [INFOTRIEVE]
- Benjamin N., Calver A., Collier J., et al, 1995. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 25: 918–923. [PUBMED], [INFOTRIEVE]
- Gerhard M., Roddy M. A., Creager S. J., et al, 1996. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension. 27: 849–853. [PUBMED], [INFOTRIEVE]